Catherine Avery Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
1,257
-177
-12% -$41.3K 0.14% 51
2026
Q1
$351K Sell
1,434
-113
-7% -$26.3K 0.16% 46
2025
Q4
$320K Hold
1,547
0.19% 45
2025
Q3
$287K Sell
1,547
-223
-13% -$38.2K 0.18% 45
2025
Q2
$270K Sell
1,770
-91
-5% -$14K 0.21% 44
2025
Q1
$309K Sell
1,861
-93
-5% -$14.6K 0.28% 40
2024
Q4
$283K Buy
+1,954
New +$303K 0.25% 43

Other funds holding JNJ

Catherine Avery Investment Management's JNJ Position: Q2 2026 in Review

Catherine Avery Investment Management reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, selling an estimated $41.3K and leaving 1,257 shares worth $319K. The position accounts for 0.14% of the portfolio, ranked #51.

Catherine Avery Investment Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $351K in Q1 2026. 4,669 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Catherine Avery Investment Management held 1,257 shares of Johnson & Johnson worth $319K as of Q2 2026.
  • Catherine Avery Investment Management sold 177 Johnson & Johnson shares in Q2 2026, an estimated $41.3K.
  • Johnson & Johnson made up 0.14% of Catherine Avery Investment Management's portfolio in Q2 2026, its #51 holding.
  • Catherine Avery Investment Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Catherine Avery Investment Management's Johnson & Johnson position peaked at $351K in Q1 2026.
  • 4,669 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.